about
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Ad...
Read More
1.84
-0.07
(-3.66%)
1.8M
XNAS Volume
XNAS 07 May, 2026 4:08 PM (EDT)
Board Meeting
The board meeting for Neuronetics Inc is scheduled for today, for the purpose of Neuronetics Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Neuronetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..